Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EURO-E.W.I.N.G.99: Chemotherapy Strategies in Ewing's Sarcoma
NCT00020566Phase 3Unknown
- Sponsor
- University of Leicester
- Start
- Feb 2001
- Primary completion
- Dec 2011
- Modality
- Small Molecules
- Countries
- 5
01
Overview
A Phase 3 trial of busulfan, melphalan in Ewing sarcoma, Peripheral Primitive Neuroectodermal Tumor (pPNET), sponsored by University of Leicester. Status: unknown.
02
Drugs
busulfanmelphalan
03
Conditions
Ewing sarcomaPeripheral Primitive Neuroectodermal Tumor (pPNET)
Beyond the preview
Go deeper on NCT00020566.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00020566.